Increased risk for EBV-lymphoma after allogeneic HSCT in adult lymphoma patients? A retrospective study of reduced compared to myeloablative conditioning.

被引：0
|
作者：
Hagglund, HG
Brune, M
Oberg, G
Hagberg, H
Theorin, N
Remberger, M
Kimby, E
机构：
[1] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden
[2] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden
[3] Univ Uppsala Hosp, Uppsala, Sweden
[4] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[5] Huddinge Univ Hosp, Karolinska Inst, Stockholm, Sweden
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5116
引用
收藏
页码：362B / 363B
页数：2
相关论文
共 50 条
  • [1] Allogeneic HSCT for adult lymphoma patients.: A retrospective study of myeloablative compared to reduced-intensity conditioning
    Hägglund, H
    Remberger, M
    Ljungman, P
    Aschan, J
    Löfgren, C
    Ringden, O
    Kimby, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S254 - S254
  • [2] High-risk of EBV lymphoma after allogeneic HSCT in adult lymphoma patients. The Swedish experience of myeloablative compared to reduced-intensity conditioning
    Hagglund, H
    Brune, M
    Oberg, G
    Hagberg, H
    Juliusson, G
    Wahlin, A
    Theorin, N
    Remberger, M
    Karolinska, EK
    BONE MARROW TRANSPLANTATION, 2005, 35 : S73 - S74
  • [3] Allogeneic transplants in follicular lymphoma: Higher risk of disease progression after reduced-intensity compared to myeloablative conditioning
    Hari, Parameswaran
    Carreras, Jeanette
    Zhang, Mei-Jie
    Gale, Robert Peter
    Bolwell, Brian J.
    Bredeson, Christopher N.
    Burns, Linda J.
    Cairo, Mitchell S.
    Freytes, Cesar O.
    Goldstein, Steven C.
    Hale, Gregory A.
    Inwards, David J.
    LeMaistre, Charles F.
    Maharaj, Dipnarine
    Marks, David I.
    Schouten, Harry C.
    Slavin, Shimon
    Vose, Julie M.
    Lazarus, Hillard M.
    van Besien, Koen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 236 - 245
  • [4] Molecular monitoring of residual disease in patients with mantle cell lymphoma and CLL after allogeneic bone marrow transplantation post reduced intensity conditioning.
    Schüler, F
    Hirt, C
    Kiefer, T
    Dolken, G
    BLOOD, 2005, 106 (11) : 435B - 435B
  • [5] Reduced-intensity conditioning for allogeneic HSCT from HLA-identical siblings in adults with myelodysplastic syndromes: a comparison with standard myeloablative conditioning. A study of the EBMT-CLWP
    Martino, R
    Van Biezen, A
    Iacobelli, S
    Brand, R
    Niederwieser, D
    De Witte, T
    BONE MARROW TRANSPLANTATION, 2004, 33 : S28 - S28
  • [6] Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT
    Nakano, Nobuaki
    Utsunomiya, Atae
    Matsuo, Keitaro
    Yoshida, Noriaki
    Seto, Masao
    Ohshima, Kouichi
    Fujiwara, Hiroshi
    Fuji, Shigeo
    Takatsuka, Yoshifusa
    Ito, Ayumu
    Miyamoto, Toshihiro
    Suehiro, Youko
    Nakamae, Hirohisa
    Sawayama, Yasushi
    Yuasa, Mitsuhiro
    Miyazaki, Yasuhiko
    Ota, Shuichi
    Imada, Kazunori
    Fukuda, Takahiro
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kato, Koji
    BLOOD ADVANCES, 2021, 5 (02) : 475 - 486
  • [7] Late events in reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with alemtuzumab (CAMPATH-1H) containing regimens impact on outcome compared with standard myeloablative conditioning.
    Ho, AYL
    Kenyon, M
    Parker, JE
    El-Hemaidi, I
    Zuckerman, M
    Devereux, S
    Pagliuca, A
    Mufti, GJ
    BLOOD, 2002, 100 (11) : 414A - 414A
  • [8] Reduced Intensity Versus Myeloablative Conditioning Allogeneic HCT for Relapsed/Refractory Lymphoma: Applying Refined Disease Risk Index (DRI) to Improve Survival
    Lazaryan, Aleksandr
    Bachanova, Veronika
    Cao, Qing
    McClune, Brian Lee
    Arora, Mukta
    Mehta, Rohtesh S.
    Wagner, John E.
    Brunstein, Claudio G.
    Weisdorf, Daniel J.
    Bejanyan, Nelli
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S225 - S226
  • [9] Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia
    Gurman, Gunhan
    Guloksuz, Gozde Aydemir
    Atilla, Erden
    Atilla, Pinar Ataca
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Ilhan, Osman
    Akan, Hamdi
    Beksac, Meral
    BLOOD, 2016, 128 (22)
  • [10] Clofarabine followed by reduced intensity conditioning as a sequential concept prior to allogeneic HSCT in three patients with advanced staged cutaneous t cell lymphoma
    Stauffer, E.
    Fraccaroli, A.
    Drolle, H.
    Flaig, M.
    Heinzerling, L.
    von Bergwelt, M.
    Theurich, S.
    Tischer, J.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 177 - 177
12345